481086035	481086035	CD	B-NP	O
|	|	NN	I-NP	O
SH	SH	NN	I-NP	O
|	|	NN	I-NP	O
09683609	09683609	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2968622	2968622	CD	B-NP	O
|	|	CC	I-NP	O
11/20/2005	11/20/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
ANGINA	ANGINA	NNP	I-NP	O
,	,	,	O	O
MYOCARDIAL	MYOCARDIAL	NNP	B-NP	O
INFARCTION	INFARCTION	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/20/2005	11/20/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/30/2005	7/30/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
SEABROOKE	SEABROOKE	NNP	B-NP	O
,	,	,	O	O
ODELL	ODELL	NNP	B-NP	O
FORREST	FORREST	NNP	I-NP	O
MD	MD	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
ON	ON	NNP	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Non-ST	Non-ST	JJ	B-NP	O
elevation	elevation	NN	I-NP	O
,	,	,	O	O
acute	acute	JJ	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
C	C	NN	I-NP	O
A	A	NN	I-NP	O
Hospital	Hospital	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Ersullcy	Ersullcy	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	NNP	B-NP	O
ILLNESS	ILLNESS	NNP	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
78-year-old	78-year-old	JJ	I-NP	O
lady	lady	NN	I-NP	O
with	with	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
and	and	CC	O	O
known	know	VBN	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
and	and	CC	O	O
status	status	NN	B-NP	O
post	post	VBP	B-VP	O
multiple	multiple	JJ	B-NP	O
PCIs	PCI	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
health	health	NN	B-NP	O
until	until	IN	B-PP	O
three	three	CD	B-NP	O
weeks	week	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
began	begin	VBD	B-VP	O
with	with	IN	B-PP	O
classical	classical	JJ	B-NP	O
paroxysmal	paroxysmal	JJ	I-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
Ordland	Ordland	NNP	B-NP	O
University	University	NNP	I-NP	O
Of	Of	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
on	on	IN	B-PP	O
three	three	CD	B-NP	O
different	different	JJ	I-NP	O
occasions	occasion	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
three	three	CD	I-NP	O
weeks	week	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Prior	Prior	RB	B-ADVP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
I.marg	I.marg	NNP	I-NP	O
Healthcare	Healthcare	NNP	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
troponin	troponin	NN	I-NP	O
leak	leak	NN	I-NP	O
of	of	IN	B-PP	O
up	up	IN	B-NP	O
to	to	TO	I-NP	O
3.6	3.6	CD	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
5	5	CD	I-NP	O
of	of	IN	B-PP	O
July	July	NNP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
15	15	CD	I-NP	O
of	of	IN	B-PP	O
June	June	NNP	B-NP	O
per	per	IN	B-PP	O
note	note	NN	B-NP	O
was	be	VBD	B-VP	O
1.1	1.1	CD	B-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
we	we	PRP	B-NP	O
admitted	admit	VBD	B-VP	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
2.6	2.6	CD	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
received	receive	VBN	I-VP	O
amikacin	amikacin	NN	B-NP	O
for	for	IN	B-PP	O
urinary	urinary	JJ	B-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Tawno	Tawno	NNP	I-NP	O
Health	Health	NNP	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
also	also	RB	I-VP	O
had	have	VBD	I-VP	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
,	,	,	O	O
abdominal	abdominal	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
pelvis	pelvis	NN	B-NP	O
contrast	contrast	NN	I-NP	O
CT	CT	NN	I-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
contrast	contrast	NN	B-NP	O
nephropathy	nephropathy	NN	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
main	main	JJ	I-NP	O
problems	problem	NNS	I-NP	O
were	be	VBD	B-VP	O
the	the	DT	B-NP	O
following	following	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
non-ST	non-ST	JJ	I-NP	O
elevation	elevation	NN	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
high-risk	high-risk	JJ	I-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
TIMI	TIMI	NN	I-NP	O
score	score	NN	I-NP	O
of	of	IN	B-PP	O
5	5	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
probably	probably	RB	B-ADVP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
factors	factor	NNS	B-NP	O
including	include	VBG	B-PP	O
contrast	contrast	NN	B-NP	O
dye	dye	NN	I-NP	O
what	what	WP	B-NP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
received	receive	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
and	and	CC	I-NP	O
amikacin	amikacin	NN	I-NP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
received	receive	VBN	I-VP	O
for	for	IN	B-PP	O
urinary	urinary	JJ	B-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
other	other	JJ	I-NP	O
problem	problem	NN	I-NP	O
was	be	VBD	B-VP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
per	per	IN	B-PP	O
report	report	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
E.	E.	NNP	B-NP	O
Coli	Coli	NNP	I-NP	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
Levaquin	Levaquin	NN	B-NP	O
and	and	CC	I-NP	O
gentamicin	gentamicin	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
past	past	JJ	I-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
was	be	VBD	B-VP	O
relevant	relevant	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
following	following	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
diabetes	diabetes	NN	B-NP	O
type	type	NN	I-NP	O
2	2	CD	I-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
diabetes	diabetes	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
anxiety	anxiety	NN	B-NP	O
disorder	disorder	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
in	in	IN	B-PP	O
1992	1992	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
PCI	PCI	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
stent	stent	JJ	I-NP	O
placed	place	VBN	B-VP	O
in	in	IN	B-PP	O
2002	2002	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
2004	2004	CD	B-NP	O
apparently	apparently	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
per	per	IN	B-PP	O
an	an	DT	B-NP	O
echo	echo	NN	I-NP	O
performed	perform	VBN	B-VP	O
at	at	IN	B-PP	O
Burg	Burg	NNP	B-NP	O
Man	Man	NNP	I-NP	O
`	`	``	O	O
stard	stard	VB	B-VP	O
Memorial	Memorial	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
was	be	VBD	B-VP	O
35	35	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
GERD	GERD	NNP	B-NP	O
and	and	CC	I-NP	O
Barrett	Barrett	NNP	I-NP	O
's	's	POS	B-NP	O
esophagus	esophagus	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
hypertension	hypertension	NN	B-NP	O
and	and	CC	I-NP	O
hypercholesterolemia	hypercholesterolemia	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
placed	place	VBN	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
hemorrhoids	hemorrhoid	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
osteoarthritis	osteoarthritis	NN	B-NP	O
with	with	IN	B-PP	O
both	both	DT	B-NP	O
knees	knee	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
spinal	spinal	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
asthma	asthma	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
allergies	allergy	NNS	I-NP	O
included	include	VBD	B-VP	O
the	the	DT	B-NP	O
following	following	NN	I-NP	O
:	:	:	O	O
Bactrim	Bactrim	NN	B-NP	O
,	,	,	O	O
penicillin	penicillin	NN	B-NP	B-protein
,	,	,	O	O
erythromycin	erythromycin	NN	B-NP	O
,	,	,	O	O
Keflex	Keflex	NNP	B-NP	O
,	,	,	I-NP	O
Metformin	Metformin	NNP	I-NP	O
,	,	,	I-NP	O
clindamycin	clindamycin	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
social	social	JJ	I-NP	O
history	history	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
nursing	nursing	NN	I-NP	O
facility	facility	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
divorced	divorce	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
four	four	CD	B-NP	O
kinds	kind	NNS	I-NP	O
.	.	.	O	O

Lives	Life	NNS	B-NP	O
in	in	IN	B-PP	O
Gle	Gle	NN	B-NP	B-protein
and	and	CC	O	O
is	be	VBZ	B-VP	O
often	often	RB	I-VP	O
visited	visit	VBN	I-VP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
temperature	temperature	NN	I-NP	O
was	be	VBD	B-VP	O
96	96	CD	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
pulse	pulse	NN	I-NP	O
77	77	CD	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
170/95	170/95	CD	B-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
admittedly	admittedly	RB	B-ADVP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
difficult	difficult	JJ	B-ADJP	O
taking	take	VBG	B-VP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
by	by	IN	B-PP	O
auscultation	auscultation	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
by	by	IN	B-PP	O
palpation	palpation	NN	B-NP	O
and	and	CC	O	O
confirmed	confirm	VBN	B-VP	O
by	by	IN	B-PP	O
Doppler	Doppler	NNP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
satting	satte	VBG	I-VP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
3.5	3.5	CD	B-NP	O
L	L	NN	I-NP	O
via	via	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
x3	x3	NN	B-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
arcus	arcus	NN	B-NP	O
senilis	senilis	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
extraocular	extraocular	JJ	I-NP	O
movements	movement	NNS	I-NP	O
are	be	VBP	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
pupils	pupil	NNS	B-NP	O
equal	equal	JJ	B-ADJP	O
,	,	,	O	O
round	round	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
reactive	reactive	JJ	B-ADJP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
showed	show	VBD	B-VP	O
bibasilar	bibasilar	JJ	B-NP	O
crackles/rales	crackles/rale	NNS	I-NP	O
two-thirds	two-third	NNS	I-NP	O
way	way	NN	I-NP	O
up	up	IN	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
JVP	JVP	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
10	10	CD	B-NP	O
cm	cm	NN	I-NP	O
water	water	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
gallop	gallop	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
rubs	rub	NNS	I-NP	O
or	or	CC	I-NP	O
murmurs	murmur	NNS	I-NP	O
heard	hear	VBN	B-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
abdomen	abdomen	NN	I-NP	O
is	be	VBZ	B-VP	O
benign	benign	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
extremities	extremity	NNS	I-NP	O
are	be	VBP	B-VP	O
warm	warm	JJ	B-ADJP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
grossly	grossly	RB	B-ADVP	O
neurologically	neurologically	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
first	first	JJ	I-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
labs	lab	NNS	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Ha	Ha	NNP	I-NP	O
Ottejaquesrence	Ottejaquesrence	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
revealed	reveal	VBD	B-VP	O
the	the	DT	B-NP	O
following	following	NN	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
140	140	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.2	4.2	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
105	105	CD	I-NP	O
,	,	,	O	O
CO2	CO2	NN	B-NP	O
24	24	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NNP	B-NP	O
40	40	CD	I-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
2.5	2.5	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	B-protein
95	95	CD	I-NP	I-protein
,	,	,	O	O
white	white	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
10.16	10.16	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
hemoglobin	hemoglobin	NN	I-NP	B-protein
of	of	IN	B-PP	O
10.0	10.0	CD	B-NP	O
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-protein
232	232	CD	B-NP	I-protein
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
1.5	1.5	CD	I-NP	I-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
BNP	BNP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
2138	2138	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-protein
lipase	lipase	NN	I-NP	I-protein
was	be	VBD	B-VP	O
7	7	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
troponin	troponin	NN	I-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
0.75	0.75	CD	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
:	:	:	O	O
Non-ST	Non-ST	JJ	B-NP	O
elevation	elevation	NN	I-NP	O
acute	acute	JJ	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
presentation	presentation	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
several	several	JJ	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
acute	acute	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
T	T	NN	B-NP	O
wave	wave	NN	I-NP	O
flattening	flattening	NN	I-NP	O
or	or	CC	I-NP	O
inversion	inversion	NN	I-NP	O
in	in	IN	B-PP	O
leads	lead	VBZ	B-VP	O
V4	V4	NN	B-NP	B-protein
to	to	TO	B-PP	O
V6	V6	NN	B-NP	B-protein
and	and	CC	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
inferior	inferior	NN	I-NP	O
leads	lead	VBZ	B-VP	O
also	also	RB	B-ADVP	O
2	2	CD	B-NP	O
,	,	,	I-NP	O
3	3	CD	I-NP	O
,	,	,	I-NP	O
aVF	aVF	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
Q-S	Q-S	JJ	B-NP	B-protein
complexes	complex	NNS	I-NP	I-protein
in	in	IN	B-PP	O
V1	V1	NN	B-NP	B-protein
through	through	IN	B-PP	O
V3	V3	NN	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
deemed	deem	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
high-risk	high-risk	JJ	I-NP	O
patient	patient	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
TIMI	TIMI	NN	I-NP	O
score	score	NN	I-NP	O
of	of	IN	B-PP	O
5and	5and	CD	B-NP	O
they	they	PRP	B-NP	O
documented	document	VBD	B-VP	O
troponin	troponin	NN	B-NP	O
leak	leak	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
managed	manage	VBN	I-VP	O
medically	medically	RB	B-ADVP	O
,	,	,	O	O
not	not	RB	B-VP	O
interventionally	interventionally	RB	I-VP	O
given	give	VBN	I-VP	O
her	her	PRP	B-NP	O
acute	acute	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
unfractionated	unfractionated	JJ	B-NP	O
heparin	heparin	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
PTT	PTT	NN	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
50	50	CD	B-NP	O
to	to	TO	I-NP	O
70	70	CD	I-NP	O
seconds	second	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
given	give	VBN	I-VP	O
eptifibatide	eptifibatide	NN	B-NP	O
intravenously	intravenously	RB	B-ADVP	O
for	for	IN	B-PP	O
five	five	CD	B-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
beta	beta	NN	B-NP	O
blockers	blocker	NNS	I-NP	O
and	and	CC	O	O
ACE	ACE	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
five	five	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
recurrent	recurrent	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
were	be	VBD	B-VP	O
persistent	persistent	JJ	B-ADJP	O
but	but	CC	O	O
her	her	PRP$	B-NP	O
troponin	troponin	NN	I-NP	O
levels	level	NNS	I-NP	O
have	have	VBP	B-VP	O
trended	trend	VBN	I-VP	O
downwards	downward	NNS	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
really	really	RB	I-VP	O
been	be	VBN	I-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
regard	regard	NN	I-NP	O
.	.	.	O	O

Regarding	Regard	VBG	B-VP	O
her	her	PRP$	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
treated	treat	VBD	B-VP	O
with	with	IN	B-PP	O
Lasix	Lasix	NN	B-NP	B-protein
initially	initially	RB	B-NP	I-protein
40	40	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
IV	IV	CD	B-NP	I-protein
Lasix	Lasix	NN	I-NP	I-protein
x1	x1	NN	I-NP	I-protein
and	and	CC	O	O
then	then	RB	B-ADVP	O
on	on	IN	B-PP	O
standing	stand	VBG	B-VP	O
PO	PO	NNP	B-NP	O
Lasix	Lasix	NNP	I-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
diuresed	diurese	VBD	B-VP	O
her	her	PRP	B-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
gave	give	VBD	B-VP	O
her	her	PRP$	B-NP	O
morphine	morphine	NN	I-NP	O
and	and	CC	I-NP	O
oxygen	oxygen	NN	I-NP	O
.	.	.	O	O

Within	Within	IN	B-PP	O
four	four	CD	B-NP	O
or	or	CC	I-NP	O
five	five	CD	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
physical	physical	JJ	I-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
much	much	RB	B-ADJP	O
better	good	JJR	I-ADJP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
crackles	crackle	NNS	I-NP	O
and	and	CC	I-NP	O
rales	rale	NNS	I-NP	O
had	have	VBD	B-VP	O
markedly	markedly	RB	I-VP	O
decreased	decrease	VBN	I-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
saturating	saturate	VBG	I-VP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
3.5	3.5	CD	B-NP	O
L	L	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
progressed	progress	VBD	B-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
oxygen	oxygen	NN	I-NP	O
requirements	requirement	NNS	I-NP	O
decreased	decrease	VBD	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
finally	finally	RB	I-VP	O
weaned	wean	VBN	I-VP	O
off	off	RP	B-PRT	O
oxygen	oxygen	NN	B-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
currently	currently	RB	I-VP	O
saturating	saturate	VBG	I-VP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
plan	plan	NN	I-NP	O
is	be	VBZ	B-VP	O
for	for	IN	B-SBAR	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
,	,	,	O	O
high-dose	high-dose	JJ	B-NP	O
Lipitor	Lipitor	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
beta-blocker	beta-blocker	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
nitrates	nitrate	NNS	B-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
acute	acute	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
records	record	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Trickvan	Trickvan	NNP	I-NP	O
Agi	Agi	NNP	I-NP	O
Health	Health	NNP	I-NP	O
Network	Network	NNP	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
had	have	VBD	B-VP	O
jumped	jump	VBN	I-VP	O
from	from	IN	B-PP	O
1.1	1.1	CD	B-NP	O
to	to	TO	B-PP	O
2.5	2.5	CD	B-NP	O
in	in	IN	B-PP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
most	most	RBS	B-ADJP	O
likely	likely	RB	I-ADJP	O
due	due	JJ	I-ADJP	O
to	to	TO	B-PP	O
intrinsic	intrinsic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
received	receive	VBN	I-VP	O
amikacin	amikacin	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
few	few	JJ	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
contrast	contrast	NN	B-NP	O
dye	dye	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
contrast	contrast	NN	B-NP	O
dye	dye	NN	I-NP	O
induced	induce	VBD	B-VP	O
nephropathy	nephropathy	NN	B-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
predialysis	predialysis	NN	I-NP	O
state	state	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
get	get	VB	I-VP	O
dialysis	dialysis	NN	B-NP	O
on	on	IN	B-PP	O
that	that	DT	B-NP	O
occasion	occasion	NN	I-NP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
simply	simply	RB	B-ADVP	O
avoided	avoid	VBD	B-VP	O
nephrotoxic	nephrotoxic	JJ	B-NP	O
agents	agent	NNS	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
judicious	judicious	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
with	with	IN	B-PP	O
strict	strict	NN	B-NP	O
?	?	.	O	O
?	?	.	O	O
____	____	''	O	B-cell_line
?	?	.	O	O
?	?	.	O	O
controls	control	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
gradually	gradually	RB	B-ADVP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
decrease	decrease	VB	I-VP	O
and	and	CC	O	O
today	today	NN	B-NP	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
1.6	1.6	CD	B-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
wise	wise	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
came	come	VBD	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
documented	document	VBN	I-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
reported	report	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	I-NP	O
gentamicin	gentamicin	NN	I-NP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
cultured	culture	VBD	B-VP	O
her	her	PRP	B-NP	O
again	again	RB	B-ADVP	O
and	and	CC	O	O
found	find	VBN	B-VP	O
E.	E.	FW	B-ADVP	O
coli	coli	FW	I-ADVP	O
more	more	JJR	B-NP	O
than	than	IN	B-PP	O
a	a	DT	B-NP	O
100	100	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	B-cell_line
colonies	colony	NNS	I-NP	I-cell_line
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
ampicillin	ampicillin	NN	B-NP	O
,	,	,	O	O
gentamicin	gentamicin	NN	B-NP	O
,	,	,	O	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
levofloxacin	levofloxacin	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
sensitive	sensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
ceftazidime	ceftazidime	NN	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
therefore	therefore	RB	B-ADVP	O
received	receive	VBD	B-VP	O
renally	renally	RB	B-NP	O
dosed	dose	VBN	I-NP	O
ceftazidime	ceftazidime	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
UTI	UTI	NN	I-NP	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
7	7	CD	I-NP	O
to	to	TO	B-PP	O
10-day	10-day	JJ	B-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
cultures	culture	NNS	I-NP	O
drawn	draw	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
24	24	CD	I-NP	O
of	of	IN	B-PP	O
April	April	NNP	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
growth	growth	NN	I-NP	O
to	to	TO	B-PP	O
date	date	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
also	also	RB	I-VP	O
been	be	VBN	I-VP	O
afebrile	afebrile	RB	B-ADJP	O
in	in	IN	B-PP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
between	between	IN	B-PP	O
7	7	CD	B-NP	O
and	and	CC	I-NP	O
11	11	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hypertension	hypertension	NN	I-NP	O
,	,	,	O	O
of	of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
measure	measure	VB	I-VP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
,	,	,	O	O
probably	probably	RB	B-ADVP	O
measuring	measure	VBG	B-VP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
arm	arm	NN	I-NP	O
by	by	IN	B-PP	O
palpation	palpation	NN	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
most	most	RBS	I-NP	O
reliable	reliable	JJ	I-NP	O
way	way	NN	I-NP	O
to	to	TO	B-VP	O
do	do	VB	I-VP	O
this	this	DT	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
here	here	RB	B-ADVP	O
with	with	IN	B-PP	O
hydralazine	hydralazine	NN	B-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
diuretics	diuretic	NNS	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
feels	feel	VBZ	B-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

Today	Today	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
told	tell	VBD	B-VP	O
me	me	PRP	B-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
filled	fill	VBN	I-VP	O
this	this	DT	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
recurrent	recurrent	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
or	or	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
98	98	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
pulse	pulse	NN	I-NP	O
ranges	range	NNS	I-NP	O
between	between	IN	B-PP	O
60	60	CD	B-NP	O
and	and	CC	I-NP	O
70	70	CD	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
is	be	VBZ	B-VP	O
between	between	IN	B-PP	O
102	102	CD	B-NP	O
and	and	CC	I-NP	O
150	150	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
satting	satte	VBG	I-VP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
current	current	JJ	I-NP	O
weight	weight	NN	I-NP	O
is	be	VBZ	B-VP	O
73	73	CD	B-NP	O
kg	kg	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
deemed	deem	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
euvolemic	euvolemic	JJ	B-ADJP	O
so	so	RB	B-NP	O
this	this	DT	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
her	her	PRP$	B-NP	O
target	target	NN	I-NP	O
weight	weight	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
ambulating	ambulate	VBG	I-VP	O
with	with	IN	B-PP	O
assistance	assistance	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
x3	x3	NN	B-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
got	get	VBN	I-VP	O
pupils	pupil	NNS	B-NP	O
equal	equal	JJ	B-ADJP	O
,	,	,	O	O
round	round	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
reactive	reactive	JJ	B-ADJP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
only	only	RB	B-NP	O
a	a	DT	I-NP	O
few	few	JJ	I-NP	O
bibasilar	bibasilar	JJ	I-NP	O
crackles	crackle	NNS	I-NP	O
on	on	IN	B-PP	O
bases	base	NNS	B-NP	O
.	.	.	O	O

Otherwise	Otherwise	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
are	be	VBP	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
gallops	gallop	NNS	I-NP	O
,	,	,	O	O
rubs	rub	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
murmurs	murmur	NNS	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
abdomen	abdomen	NN	I-NP	O
is	be	VBZ	B-VP	O
benign	benign	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
extremities	extremity	NNS	I-NP	O
are	be	VBP	B-VP	O
warm	warm	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
right	right	JJ	I-NP	O
calf	calf	NN	I-NP	O
is	be	VBZ	B-VP	O
quite	quite	RB	I-VP	O
tender	tender	VB	I-VP	O
to	to	TO	B-PP	O
palpation	palpation	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
documented	document	VBN	I-NP	O
old	old	JJ	I-NP	O
DVT	DVT	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
gastrocnemius	gastrocnemius	NN	I-NP	O
vein	vein	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
old	old	JJ	B-ADJP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
probably	probably	RB	I-VP	O
got	get	VBN	I-VP	O
some	some	DT	B-NP	O
postphlebitic	postphlebitic	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
and	and	CC	O	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
neurologically	neurologically	RB	B-ADVP	O
grossly	grossly	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
laboratories	laboratory	NNS	I-NP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
include	include	VBP	B-VP	O
the	the	DT	B-NP	O
following	following	NN	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
139	139	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.7	4.7	CD	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
is	be	VBZ	B-VP	O
1.6	1.6	CD	B-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
50	50	CD	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
is	be	VBZ	B-VP	O
11.01	11.01	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
28.5	28.5	CD	I-NP	I-protein
,	,	,	O	O
hemoglobin	hemoglobin	NN	B-NP	B-protein
9.2	9.2	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
platelets	platelet	NNS	B-NP	B-cell_type
258	258	CD	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
of	of	IN	B-PP	O
1.2	1.2	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
include	include	VBP	B-VP	O
the	the	DT	B-NP	O
following	following	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Enteric-coated	Enteric-coated	JJ	B-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
orally	orally	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Ceftazidime	Ceftazidime	NN	B-NP	O
1	1	CD	I-NP	O
g	g	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
24h	24h	NN	I-NP	O
.	.	.	O	O

until	until	IN	B-SBAR	O
August	August	NNP	B-NP	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
7-day	7-day	JJ	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
orally	orally	RB	B-NP	O
twice	twice	RB	I-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
in	in	IN	B-PP	O
case	case	NN	B-NP	O
of	of	IN	B-PP	O
constipation	constipation	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
orally	orally	RB	B-NP	O
every	every	DT	I-NP	O
12	12	CD	I-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Heparin	Heparin	NN	B-NP	B-protein
5000	5000	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
bedridden	bedridden	JJ	B-ADJP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Isosorbide	Isosorbide	NN	B-NP	O
dinitrate	dinitrate	NN	I-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
orally	orally	RB	B-ADVP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Lopressor	Lopressor	NN	B-NP	O
37.5	37.5	CD	I-NP	O
mg	mg	NN	I-NP	O
orally	orally	RB	B-ADVP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
with	with	IN	B-PP	O
hold	hold	NN	B-NP	O
parameters	parameter	NNS	I-NP	O
,	,	,	O	O
hold	hold	VBP	B-VP	O
if	if	IN	B-SBAR	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
110	110	CD	I-NP	O
,	,	,	O	O
or	or	CC	O	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
55	55	CD	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Sublingual	Sublingual	JJ	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Vicodin	Vicodin	NN	B-NP	O
one	one	CD	I-NP	O
tablet	tablet	NN	I-NP	O
every	every	DT	B-NP	O
six	six	CD	I-NP	O
hours	hour	NNS	I-NP	O
in	in	IN	B-PP	O
case	case	NN	B-NP	O
of	of	IN	B-PP	O
pain	pain	NN	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Risperidone	Risperidone	NN	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
orally	orally	RB	B-ADVP	O
once	once	RB	I-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Lipitor	Lipitor	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
orally	orally	RB	B-ADVP	O
once	once	RB	I-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
orally	orally	RB	B-ADVP	O
once	once	RB	I-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Celexa	Celexa	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
orally	orally	RB	B-ADVP	O
once	once	RB	I-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Esomeprazole	Esomeprazole	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
orally	orally	RB	B-ADVP	O
once	once	RB	I-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Lantus	Lantus	NNP	B-NP	O
17	17	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
every	every	DT	B-NP	O
morning	morning	NN	I-NP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

Novolog	Novolog	NN	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
AND	AND	CC	I-NP	O
PLAN	PLAN	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
go	go	VB	I-VP	O
to	to	TO	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
.	.	.	O	O

Things	Thing	NNS	B-NP	O
to	to	TO	B-VP	O
do	do	VB	I-VP	O
specifically	specifically	RB	B-ADVP	O
include	include	VBP	B-VP	O
the	the	DT	B-NP	O
following	following	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
to	to	TO	B-VP	O
achieve	achieve	VB	I-VP	O
a	a	DT	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
72	72	CD	B-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
ceftazidime	ceftazidime	NN	B-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
until	until	IN	B-PP	O
August	August	NNP	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
calf	calf	NN	I-NP	O
pain	pain	NN	I-NP	O
-	-	HYPH	B-NP	O
DVT	DVT	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
,	,	,	O	O
one	one	CD	B-NP	O
possibly	possibly	RB	B-ADVP	O
to	to	TO	B-VP	O
raise	raise	VB	I-VP	O
the	the	DT	B-NP	O
Clevewill	Clevewill	NNP	I-NP	O
Ent	Ent	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
as	as	IN	B-SBAR	O
this	this	DT	B-NP	O
may	may	MD	B-VP	O
represent	represent	VB	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
cold	cold	JJ	I-NP	O
malignancy	malignancy	NN	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
may	may	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
worked	work	VBN	I-VP	O
up	up	RP	B-PRT	O
once	once	RB	B-ADVP	O
the	the	DT	B-NP	O
acute	acute	JJ	I-NP	O
setting	setting	NN	I-NP	O
is	be	VBZ	B-VP	O
over	over	RB	B-ADVP	O
.	.	.	O	O

Studies	Study	NNS	B-NP	O
performed	perform	VBN	B-VP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
hospital	hospital	NN	I-NP	O
include	include	VBP	B-VP	O
the	the	DT	B-NP	O
following	following	NN	I-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
renal	renal	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
as	as	IN	B-PP	O
part	part	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
workup	workup	NN	I-NP	O
for	for	IN	B-PP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
reveal	reveal	VBP	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
kidney	kidney	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
size	size	NN	I-NP	O
of	of	IN	B-PP	O
11.8	11.8	CD	B-NP	O
cm	cm	NN	I-NP	O
and	and	CC	O	O
apical	apical	JJ	B-NP	O
cortical	cortical	JJ	I-NP	O
cyst	cyst	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
kidney	kidney	NN	B-NP	O
10.6	10.6	CD	I-NP	O
cm	cm	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
hydronephrosis	hydronephrosis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
MIBI	MIBI	NN	I-NP	B-DNA
,	,	,	O	O
SPECT	SPECT	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
the	the	DT	B-NP	O
following	following	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
combined	combine	VBN	I-NP	O
?	?	.	O	O
?	?	.	O	O
____	____	''	O	B-cell_line
?	?	.	O	O
?	?	.	O	O
ischemia	ischemia	NN	B-NP	O
plus	plus	CC	I-NP	O
scar	scar	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
stress	stress	NN	I-NP	O
were	be	VBD	B-VP	O
moderately	moderately	RB	B-ADJP	O
abnormal	abnormal	JJ	I-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
summed	summed	JJ	I-NP	O
stress	stress	NN	I-NP	O
score	score	NN	I-NP	O
of	of	IN	B-PP	O
9	9	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
rest	rest	NN	I-NP	O
LV	LV	NN	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
was	be	VBD	B-VP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
PET	PET	NN	I-NP	O
CT	CT	NN	I-NP	O
test	test	NN	I-NP	O
results	result	NNS	I-NP	O
were	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
and	and	CC	O	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
septal	septal	JJ	I-NP	O
area	area	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
a	a	DT	B-NP	O
focus	focus	NN	I-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
OM	OM	NN	I-NP	O
territory	territory	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
abnormal	abnormal	JJ	B-NP	O
global	global	JJ	I-NP	O
LV	LV	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
function	function	NN	I-NP	O
and	and	CC	O	O
these	these	DT	B-NP	O
results	result	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
in	in	IN	B-PP	O
interval	interval	NN	B-NP	O
progressing	progress	VBG	B-VP	O
per	per	IN	B-PP	O
her	her	PRP$	B-NP	O
prior	prior	JJ	I-NP	O
study	study	NN	I-NP	O
performed	perform	VBN	B-VP	O
on	on	IN	B-PP	O
November	November	NNP	B-NP	O
,	,	,	O	O
2004	2004	CD	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
8-9628375	8-9628375	CD	B-NP	O
ISSten	ISSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Beau	Beau	NNP	B-NP	O
Yong	Yong	NNP	I-NP	O
Mccarron	Mccarron	NNP	I-NP	O
MD	MD	NNP	I-NP	O
Ine	Ine	NNP	I-NP	O
Spodes	Spodes	NNP	I-NP	O
Land	Land	NNP	I-NP	O
Sa	Sa	NNP	I-NP	O
Hison	Hison	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Bernard	Bernard	NNP	B-NP	O
Thormahlen	Thormahlen	NNP	I-NP	O
Tua	Tua	NNP	I-NP	O
Health	Health	NNP	I-NP	O
Services	Service	NNPS	I-NP	O
Sgrove	Sgrove	NNP	I-NP	O
Noville	Noville	NNP	I-NP	O
Reve	Reve	NNP	I-NP	O
Thouleighrocksamontotte	Thouleighrocksamontotte	NNP	I-NP	O
Hunt	Hunt	NNP	I-NP	O
U	U	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
LIDTKE	LIDTKE	NNP	B-NP	O
,	,	,	O	O
WESTON	WESTON	NNP	B-NP	O
EMMANUEL	EMMANUEL	NNP	I-NP	O
BOB	BOB	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
CASELLO	CASELLO	NNP	B-NP	O
,	,	,	O	O
RUDY	RUDY	NNP	B-NP	O
MONTY	MONTY	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
0452748	0452748	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
9/19/05	9/19/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
9/19/05	9/19/05	CD	B-NP	O

